Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics

Until now, there are no approved treatment against COVID-19. Hydroxychloroquine (HCQ) was hypothesized to be active against SARS-CoV2 via antiviral and anti-inflammatory effect; however, HCQ for COVID-19 in clinical use remained debating. In this preliminary report, we presented six patients with mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wang-Da, Chang, Sui-Yuan, Lan, Ting-Yuan, Lin, Yen-Chun, Kao, Jui-Hung, Liao, Chun-Hua, Tsai, Ming-Jui, Kuo, Po-Hsien, Huang, Yu-Shan, Wang, Jann-Tay, Sheng, Wang-Huei, Hsieh, Song-Chou, Chiang, Bor-Luen, Chen, Yee-Chun, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Formosan Medical Association. Published by Elsevier Taiwan LLC. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447255/
https://www.ncbi.nlm.nih.gov/pubmed/32888840
http://dx.doi.org/10.1016/j.jfma.2020.08.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447255/
https://www.ncbi.nlm.nih.gov/pubmed/32888840
http://dx.doi.org/10.1016/j.jfma.2020.08.022

Ejemplares similares